Orrick Advises SFJ Pharmaceuticals on Acquisition of Bentracimab Assets from PhaseBio
January.18.2023

Orrick advised SFJ on its acquisition of assets related to the drug Bentracimab from PhaseBio.
January.18.2023
Orrick advised SFJ on its acquisition of assets related to the drug Bentracimab from PhaseBio.
January.09.2023
December.28.2022
November.11.2022
November.03.2022
October.17.2022
September.01.2022
The investment marks the first time MY DR NOW has received external capital.
September.01.2022
After a long and complex prenotification phase before the European Commission, Orrick obtained an early unconditional clearance of the transaction.
August.03.2022
July.25.2022
July.08.2022
by Joseph Perkins and Stephen Thau | January.17.2023
Joseph Perkins and Stephen Thau explain how early-stage biotech startups can use DAOs to provide an alternative to traditional sources of capital.
by Gargi Talukder, Jennifer Ng, Jessica Stern and Alex Straughn | December.15.2022
by Gargi Talukder, Jennifer Ng, Jessica Stern and Alex Straughn | December.01.2022
How the right level of IP due diligence can help inform investment decisions in the life sciences arena.
November.30.2022
ESG factors are increasingly important in the life sciences. Managing ESG risks and opportunities can be an important source of long-term value.
November.15.2022
by Thora Johnson, Hannah Levin, Cameron Carr and Michaela Frai | October.25.2022
The last year has seen a multijurisdictional regulatory push for increased cybersecurity standards for medical devices. Here's what you need to know.
October.24.2022
October.21.2022
Two of our partners and an Andersen director author Law360 article on tax implications in LSC collaboration deals.
by Franklin Monsour | September.19.2022
Franklin Monsour posted this article on Law360 on taking more FCA cases to trial.
by Thora Johnson | August.10.2022
EU & US Privacy and Security Considerations for Covid-19 Data Processing Activities From Pandemic to Living with Covid written by Thora Johnson.
by Thora Johnson, Kyle Kessler and Alyssa Wolfington | July.28.2022
Our lawyers wrote Newsweek opinion piece calling for federal legislation to address privacy vulnerabilities after Dobbs.
July.27.2022
July.15.2022
November.15.2022
November.07.2022
September.09.2022
August.08.2022
August.01.2022
May.31.2022
Congratulations to Orrick partner Gregg Griner on being recognized as a Go-To Lawyer for Healthcare and Life Sciences by Massachusetts Lawyers Weekly.
February.22.2022
January.03.2022
October.11.2021
Orrick welcomes Franklin Monsour, a former federal prosecutor and experienced white collar and regulatory adviser to the life sciences sector.
September.27.2021